385 related articles for article (PubMed ID: 15920762)
1. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
[TBL] [Abstract][Full Text] [Related]
2. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
3. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
4. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
Chen KC; Zhou Y; Zhang W; Lou MF
Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
[TBL] [Abstract][Full Text] [Related]
5. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
6. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism.
Rodrigues AR; Pignatelli D; Almeida H; Gouveia AM
Mol Cell Endocrinol; 2009 May; 303(1-2):74-81. PubMed ID: 19428994
[TBL] [Abstract][Full Text] [Related]
8. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells.
Goppelt-Struebe M; Fickel S; Reiser CO
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497
[TBL] [Abstract][Full Text] [Related]
9. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.
Greco S; Muscella A; Elia MG; Salvatore P; Storelli C; Mazzotta A; Manca C; Marsigliante S
J Cell Physiol; 2003 Aug; 196(2):370-7. PubMed ID: 12811831
[TBL] [Abstract][Full Text] [Related]
11. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
Lee MY; Jo SD; Lee JH; Han HJ
J Cell Biochem; 2008 Dec; 105(6):1410-9. PubMed ID: 18980246
[TBL] [Abstract][Full Text] [Related]
12. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
Wu Y; Chen Z; Ullrich A
Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors.
Olivares-Reyes JA; Shah BH; Hernández-Aranda J; García-Caballero A; Farshori MP; García-Sáinz JA; Catt KJ
Mol Pharmacol; 2005 Aug; 68(2):356-64. PubMed ID: 15905421
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation.
Jiménez-Sainz MC; Fast B; Mayor F; Aragay AM
Mol Pharmacol; 2003 Sep; 64(3):773-82. PubMed ID: 12920215
[TBL] [Abstract][Full Text] [Related]
16. Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes.
Shah BH; Alberto Olivares-Reyes J; Yesilkaya A; Catt KJ
Mol Endocrinol; 2002 Mar; 16(3):610-20. PubMed ID: 11875120
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
18. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
He S; Dibas A; Yorio T; Prasanna G
Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.
Chan AS; Wong YH
Br J Pharmacol; 2004 Jun; 142(4):635-46. PubMed ID: 15172963
[TBL] [Abstract][Full Text] [Related]
20. H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells.
Zhuang S; Schnellmann RG
Am J Physiol Renal Physiol; 2004 May; 286(5):F858-65. PubMed ID: 15075181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]